Italia Bongarzone

Italia Bongarzone

UNVERIFIED PROFILE

Are you Italia Bongarzone?   Register this Author

Register author
Italia Bongarzone

Italia Bongarzone

Publications by authors named "Italia Bongarzone"

Are you Italia Bongarzone?   Register this Author

46Publications

972Reads

9Profile Views

Lipid accumulation in human breast cancer cells injured by iron depletors.

J Exp Clin Cancer Res 2018 Apr 3;37(1):75. Epub 2018 Apr 3.

Fondazione IRCCS Istituto Nazionale dei Tumori, via G. Amadeo 42, Milan, 20133, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s13046-018-0737-zDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5883539PMC
April 2018

Multiple viral infections in primary effusion lymphoma: a model of viral cooperation in lymphomagenesis.

Expert Rev Hematol 2017 06 16;10(6):505-514. Epub 2017 May 16.

e Department of Pathology , Centro di Riferimento Oncologico - IRCCS, National Cancer Institute , Aviano , Italy.

View Article

Download full-text PDF

Source
https://www.tandfonline.com/doi/full/10.1080/17474086.2017.1
Publisher Site
http://dx.doi.org/10.1080/17474086.2017.1326815DOI Listing
June 2017

Plasma hepcidin in early-stage breast cancer patients: no relationship with interleukin-6, erythropoietin and erythroferrone.

Expert Rev Proteomics 2015 23;12(6):695-701. Epub 2015 Oct 23.

b Laboratory of Proteomics , Fondazione IRCCS Istituto Nazionale dei Tumori , Milan , Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1586/14789450.2015.1099436DOI Listing
January 2017

MIF/CD74 axis is a target for novel therapies in colon carcinomatosis.

J Exp Clin Cancer Res 2017 01 23;36(1):16. Epub 2017 Jan 23.

Department of Experimental Oncology and Molecular Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori, via G. Amadeo 42, Milan, 20133, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s13046-016-0475-zDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5260021PMC
January 2017

Applicability of Under Vacuum Fresh Tissue Sealing and Cooling to Omics Analysis of Tumor Tissues.

Biopreserv Biobank 2016 Dec 12;14(6):480-490. Epub 2016 Jul 12.

1 Department of Experimental Oncology and Molecular Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori , Milan, Italy .

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1089/bio.2015.0093DOI Listing
December 2016

Cell-secreted signals shape lymphoma identity.

Semin Cancer Biol 2015 Oct 30;34:81-91. Epub 2015 Mar 30.

Proteomics Laboratory, Department of Experimental Oncology and Molecular Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori, Milano, Italy. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.semcancer.2015.02.001DOI Listing
October 2015

4-IPP, a selective MIF inhibitor, causes mitotic catastrophe in thyroid carcinomas.

Endocr Relat Cancer 2015 Oct 23;22(5):759-75. Epub 2015 Jul 23.

Proteomics LaboratoryDepartment of Experimental Oncology and Molecular MedicineDepartment of Diagnostic Pathology and Laboratory MedicineDepartment of Predictive and Preventive MedicineFondazione IRCCS Istituto Nazionale dei Tumori, Via Amadeo 42, 20133 Milan, ItalyLaboratory of Clinical Pathology and Medical GeneticsFondazione IRCCS 'Carlo Besta' Istituto Neurologico, Via Amadeo 42, 20133 Milan, Italy

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1530/ERC-15-0299DOI Listing
October 2015

Preliminary Evidence on the Diagnostic and Molecular Role of Circulating Soluble EGFR in Non-Small Cell Lung Cancer.

Int J Mol Sci 2015 Aug 19;16(8):19612-30. Epub 2015 Aug 19.

Laboratory of Translational Research, Research and Statistic Infrastructure, IRCCS Arcispedale Santa Maria Nuova, Reggio Emilia 42123, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3390/ijms160819612DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4581315PMC
August 2015

Stratification of clear cell renal cell carcinoma by signaling pathway analysis.

Expert Rev Proteomics 2014 Apr 27;11(2):237-49. Epub 2014 Feb 27.

Department of Experimental Oncology and Molecular Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori , Milan , Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1586/14789450.2014.893193DOI Listing
April 2014

Primary effusion lymphoma: secretome analysis reveals novel candidate biomarkers with potential pathogenetic significance.

Am J Pathol 2014 Mar 10;184(3):618-30. Epub 2014 Feb 10.

Proteomics Laboratory, Department of Experimental Oncology and Molecular Medicine, Fondazione IRCCS, Istituto Nazionale dei Tumori, Milano.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ajpath.2013.11.028DOI Listing
March 2014

Is Wilms tumor a candidate neoplasia for treatment with WNT/β-catenin pathway modulators?--A report from the renal tumors biology-driven drug development workshop.

Mol Cancer Ther 2013 Dec 20;12(12):2619-27. Epub 2013 Nov 20.

Corresponding Author: Kathy Pritchard-Jones, Hugh and Catherine Stevenson Professor of Pediatric Oncology, UCL Institute of Child Health, 30 Guilford Street, London WC1N 1EH, United Kingdom.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1535-7163.MCT-13-0335DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3858246PMC
December 2013

Bioinformatics tools for secretome analysis.

Biochim Biophys Acta 2013 Nov 5;1834(11):2442-53. Epub 2013 Feb 5.

Proteomics Laboratory, Department of Experimental Oncology and Molecular Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbapap.2013.01.039DOI Listing
November 2013

Extracavitary KSHV-positive solid lymphoma: a large B-cell lymphoma within the spectrum of primary effusion lymphoma.

Am J Surg Pathol 2013 Sep;37(9):1460-1

*Department of Pathology Centro di Riferimento Oncologico Aviano, Istituto Nazionale Tumori IRCCS, Aviano †Department of Diagnostic Pathology and Laboratory Medicine ‡Proteomics Laboratory, Department of Experimental Oncology and Molecular Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori, Milano, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/PAS.0b013e31829caadaDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4033663PMC
September 2013

Soluble epidermal growth factor receptor isoforms in non-small cell lung cancer tissue and in blood.

Lung Cancer 2012 Jun 15;76(3):332-8. Epub 2011 Dec 15.

Molecular Biology Laboratory, Department of Oncology, Azienda Ospedaliera ASMN, Istituto di Ricovero e Cura a Carattere Scientifico, Reggio Emilia, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.lungcan.2011.11.018DOI Listing
June 2012

Interplay between Ret and Fap-1 regulates CD95-mediated apoptosis in medullary thyroid cancer cells.

Biochem Pharmacol 2011 Oct 2;82(7):778-88. Epub 2011 Jul 2.

Molecular Pharmacology Unit, Department of Experimental Oncology and Molecular Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bcp.2011.06.037DOI Listing
October 2011

Serological identification of HSP105 as a novel non-Hodgkin lymphoma therapeutic target.

Blood 2011 Oct 22;118(16):4421-30. Epub 2011 Aug 22.

C. Gandini Medical Oncology, Bone Marrow Transplantation Unit, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico, Istituto Nazionale per lo Studio e la Cura dei Tumori, Milan, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2011-06-364570DOI Listing
October 2011

Secretome compartment is a valuable source of biomarkers for cancer-relevant pathways.

J Proteome Res 2011 Sep 29;10(9):4196-207. Epub 2011 Jul 29.

Proteomics Laboratory, Department of Experimental Oncology and Molecular Medicine, Fondazione IRCCS Istituto Nazionale Tumori, Milan, Italy.

View Article

Download full-text PDF

Source
http://pubs.acs.org/doi/abs/10.1021/pr200344n
Publisher Site
http://dx.doi.org/10.1021/pr200344nDOI Listing
September 2011

Proteomic detection of a large amount of SCGFα in the stroma of GISTs after imatinib therapy.

J Transl Med 2011 Sep 23;9:158. Epub 2011 Sep 23.

Proteomics Laboratory, Department of Experimental Oncology and Molecular Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/1479-5876-9-158DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3192683PMC
September 2011

Functional characterization of the MTC-associated germline RET-K666E mutation: evidence of oncogenic potential enhanced by the G691S polymorphism.

Endocr Relat Cancer 2011 Aug 25;18(4):519-27. Epub 2011 Jul 25.

Operative Unit Molecular Mechanisms, Department of Experimental Oncology, IRCCS Istituto Nazionale dei Tumori Foundation, Milan, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1530/ERC-10-0306DOI Listing
August 2011

Improved clinical outcome in indolent B-cell lymphoma patients vaccinated with autologous tumor cells experiencing immunogenic death.

Cancer Res 2010 Nov 30;70(22):9062-72. Epub 2010 Sep 30.

C. Gandini Medical Oncology, Bone Marrow Transplantation Unit, Department of Experimental Oncology, Fondazione Istituti di Ricovero e Cura a Carattere Scientifico, Istituto Nazionale per lo Studio e la Cura dei Tumori, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/0008-5472.CAN-10-1825DOI Listing
November 2010

Dasatinib reduces FAK phosphorylation increasing the effects of RPI-1 inhibition in a RET/PTC1-expressing cell line.

Mol Cancer 2010 Oct 18;9:278. Epub 2010 Oct 18.

Department of Experimental Oncology and Molecular Medicine, Proteomics Laboratory, Fondazione IRCCS Istituto Nazionale Tumori, Milan, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/1476-4598-9-278DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2967544PMC
October 2010

Proteome profile in Myotonic Dystrophy type 2 myotubes reveals dysfunction in protein processing and mitochondrial pathways.

Neurobiol Dis 2010 May 4;38(2):273-80. Epub 2010 Feb 4.

Dipartimento di Scienze Biomolecolari e Biotecnologie, Università degli Studi di Milano, Milan, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.nbd.2010.01.017DOI Listing
May 2010

Impact of biospecimens handling on biomarker research in breast cancer.

BMC Cancer 2009 Nov 24;9:409. Epub 2009 Nov 24.

Fondazione Istituto FIRC di Oncologia Molecolare, Via Adamello16, 20139 Milano, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/1471-2407-9-409DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2787533PMC
November 2009

Proteomic identification of LASP-1 down-regulation after RNAi urokinase silencing in human hepatocellular carcinoma cells.

Neoplasia 2009 Feb;11(2):207-19

Department of Biomedical Sciences and Biotechnology, Division of Biology and Genetics, IDET Centre of Excellence, University of Brescia, Brescia, Italy.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2631145PMC
http://dx.doi.org/10.1593/neo.81076DOI Listing
February 2009

The ALCAM shedding by the metalloprotease ADAM17/TACE is involved in motility of ovarian carcinoma cells.

Mol Cancer Res 2007 Dec;5(12):1246-53

Department of Translational Oncology, Istituto Nazionale per la Ricerca sul Cancro, Genoa, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1541-7786.MCR-07-0060DOI Listing
December 2007

Regulation of breast cancer response to chemotherapy by fibulin-1.

Cancer Res 2007 May;67(9):4271-7

Molecular Biology Unit, Department of Experimental Oncology, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico, Istituto Nazionale per lo Studio e la Cura dei Tumori, Milan, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/0008-5472.CAN-06-4162DOI Listing
May 2007

Molecular predictors of response and outcome in ovarian cancer.

Crit Rev Oncol Hematol 2006 Oct 7;60(1):19-37. Epub 2006 Jul 7.

Unit of Molecular Therapies, Department of Experimental Oncology, Istituto Nazionale Tumori, 20133-Milan, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.critrevonc.2006.03.003DOI Listing
October 2006

A novel activating mutation in the RET tyrosine kinase domain mediates neoplastic transformation.

Mol Endocrinol 2006 Jul 9;20(7):1633-43. Epub 2006 Feb 9.

Cambridge Institute for Medical Research, Cancer Research UK Department of Oncology, University of Cambridge, Hills Road, Cambridge CB2 2XY, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1210/me.2004-0447DOI Listing
July 2006

The Ret(C620R) mutation affects renal and enteric development in a mouse model of Hirschsprung's disease.

Am J Pathol 2006 Apr;168(4):1262-75

Department of Experimental Oncology and Laboratories, Istituto Nazionale per lo Studio e la Cura dei Tumori, Via G. Venezian 1, 20133 Milan, Italy.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1606559PMC
http://dx.doi.org/10.2353/ajpath.2006.050607DOI Listing
April 2006

90Y Labeling of monoclonal antibody MOv18 and preclinical validation for radioimmunotherapy of human ovarian carcinomas.

Cancer Immunol Immunother 2005 Dec 31;54(12):1200-13. Epub 2005 May 31.

Unit of Nuclear Medicine, Istituto Nazionale Tumori, via Venezian 1, 20133 Milano, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00262-005-0693-2DOI Listing
December 2005

Internalization and recycling of ALCAM/CD166 detected by a fully human single-chain recombinant antibody.

J Cell Sci 2005 Apr 15;118(Pt 7):1515-25. Epub 2005 Mar 15.

Istituto Nazionale per la Ricerca sul Cancro, Largo R. Benzi 10, 16132 Genova, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1242/jcs.02280DOI Listing
April 2005

The molecular basis of thyroid epithelial tumorigenesis.

Tumori 2003 Sep-Oct;89(5):514-6

Department of Experimental Oncology, National Cancer Institute, Milan, Italy.

View Article

Download full-text PDF

Source
February 2004

RETMEN2A and RETMEN2B oncoproteins are targets of PP1 inhibitor.

Tumori 2003 Sep-Oct;89(5):550-2

Department of Experimental Oncology, National Cancer Institute, Milan, Italy.

View Article

Download full-text PDF

Source
February 2004

PP1 inhibitor induces degradation of RETMEN2A and RETMEN2B oncoproteins through proteosomal targeting.

Cancer Res 2003 May;63(9):2234-43

Department of Experimental Oncology, Istituto Nazionale Tumori, 20133 Milan, Italy.

View Article

Download full-text PDF

Source
May 2003